Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 17:12:682980.
doi: 10.3389/fgene.2021.682980. eCollection 2021.

Non-invasive Prenatal Testing, What Patients Do Not Learn, May Be Due to Lack of Specialist Genetic Training by Gynecologists and Obstetricians?

Affiliations
Review

Non-invasive Prenatal Testing, What Patients Do Not Learn, May Be Due to Lack of Specialist Genetic Training by Gynecologists and Obstetricians?

Thomas Liehr. Front Genet. .

Abstract

Platforms for "non-invasive prenatal testing" (NIPT), or also referred to as "non-invasive prenatal screening" (NIPS) have been available for over 10 years, and are the most recent tools available to obtain information about genetic condition(s) of an unborn child. The highly praised advantage of NIPT-screening is that results can provide early hints on the detection of fetal trisomies and gonosomal numerical aberrations as early as the 10th week of gestation onward, without any need for invasive procedures, such as amniocenteses or alternatives. Understandably, the public along with gynecologists and obstetricians eagerly await these early test results. Their general hope for normal (=negative) test results is also justified, as in >95% of the tested cases such an outcome is to be expected. However, pregnant women can be disappointed and confused, particularly regarding the genetic information and proposed care when the results are positive, and these emotions are also common with false-positive and false-negative NIPT results. Finally, such concerns in understanding the advantages and limitations of this routinely ordered screening tool end up at Clinical Geneticists and Genetic counselors. In this review, general background on NIPT, differences of NIPT platforms, advantages and limitations of NIPT, as well as consequences of insufficient counseling before and after NIPT are summarized. To provide comprehensive care in all pregnancies situations, professionals need a careful attitude toward offering NIPT along with specially training and qualifications in counseling for these procedures. Often it is gynecologists and obstetricians who discuss the use of NIPT with patients; however, although these physicians have a highly qualified background and knowledge in their respective specialty area(s), they may lack specific training on the interpretation of NIPT-screening results. These potential knowledge gaps must be closed quickly and comprehensively by the corresponding scientific societies to ensure optimal patient care.

Keywords: NIPT-short-cuts; background knowledge; cell-free placental DNA; massively parallel sequencing; non-invasive prenatal testing; qualified genetic counseling; single nucleotide polymorphism whole genomic sequencing.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Agarwal A., Sayres L. C., Cho M. K., Cook-Deegan R., Chandrasekharan S. (2013). Commercial landscape of noninvasive prenatal testing in the United States. Prenat. Diagn. 33 521–531. 10.1002/pd.4101 - DOI - PMC - PubMed
    1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics, Committee on Genetics, Society for Maternal-Fetal Medicine (2020). Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226. Obstet. Gynecol. 136 e48–e69. - PubMed
    1. Andari M. V. C., Bussamra S. L. C., Tedesco T. G. D., Peixoto P. A. B., Pares P. D. B. S., Braga A., et al. (2020). Noninvasive prenatal testing: benefits and limitations of the available tests. Ceska Gynekol. 85 41–48. - PubMed
    1. Anderson J., Ghaffarian K. R. (2021). “Early pregnancy diagnosis,” in StatPearls [Internet], (Treasure Island (FL): StatPearls Publishing; ). - PubMed
    1. Beaudet A. L. (2016). Using fetal cells for prenatal diagnosis: history and recent progress. Am. J. Med. Genet. C Semin. Med. Genet. 172 123–127. 10.1002/ajmg.c.31487 - DOI - PubMed

LinkOut - more resources